This Glaucoma Therapy Company Is Keeping An Eye On Profits

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 5 hours ago

Feel like a pumpkin-spice burrito? Analysts try to wrap their heads around a possible Starbucks-Chipotle tie-up.

Starbucks investors would likely not be happy about the company adding debt to finance a deal to buy Chipotle, given that it already has a high debt load.

MarketWatch

marketsabout 6 hours ago

Micron, Nvidia and AI chip stocks fall as report on OpenAI’s revenue causes ‘undue concern’

OpenAI’s annualized revenue reportedly fell short of expectations — but analysts say that reflects differences in how the figure is reported, not weakness in AI demand.

MarketWatch

marketsabout 6 hours ago

Why a longtime skeptic of Palantir’s stock is finally saying it’s time to buy

Palantir’s total addressable market could get a lot bigger, while its business model should sustain its lead against competitors, an analyst says

MarketWatch